Study S000240

Acute Effects of a Glucagon-like Peptide 1 Analog, Exenatide, on Gastrointestinal Motor Function and Permeability in Patients With Short Bowel Syndrome on Home Parenteral Nutrition

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01818648
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: QUADRUPLE
Status: WITHDRAWN
Enrollment: 0
Start: 2013-03
Primary completion: 2014-01
Lead sponsor: Mayo Clinic
Conditions: Short Bowel Syndrome
Interventions: DRUG:Exenatide; DRUG:Placebo
Results posted: FALSE

Registered primary outcomes

Change in 24hr Gastrointestinal and Colonic Transit before and after Exenatide vs placebo [In both arms participants will undergo GI transit measurements on 2 seperate occasions for a total of 24 hours, with a wash out period of 48 hours in between transit studies.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.